BIRC3 RNA Editing Modulates Lipopolysaccharide-Induced Liver Inflammation: Potential Implications for Animal Health.

Area of Science:

• Molecular Biology
• Genomics
• Immunology

Background:

• Bacterial lipopolysaccharide (LPS) is a major cause of liver inflammation and damage in animals and humans.
• The role of RNA editing in LPS-induced liver injury remains largely unexplored.

Purpose of the Study:

• To investigate the role of RNA editing in LPS-induced liver injury using a mouse model.
• To identify specific RNA editing events and genes involved in the inflammatory response to LPS.

Main Methods:

• Administration of LPS to mice to create a liver injury model.
• RNA editing omics (RE-seq) to analyze RNA editing events.
• Integration of gene expression profiles and nine-quadrant analysis.

Main Results:

• Significant differences in RNA editing were observed between LPS-treated and control mice.
• 354 differentially edited genes were identified, enriched in apoptosis, mTOR, oxidative stress, and Nf-Kappa B signaling pathways.
• The gene Birc3 exhibited significantly higher editing and expression in the LPS group, linking it to liver inflammation and damage.

Conclusions:

• RNA editing plays a crucial role in LPS-induced liver inflammation and damage.
• Aberrant RNA editing of Birc3 represents a novel mechanism contributing to LPS-induced liver pathology.
• These findings offer potential new therapeutic strategies for LPS-related liver diseases.